Scientists achieve milestone in animal-free production of biologics For the first time, scientists have successfully produced sugar-based biologic molecules utilizing bacteria, without the need for animal products. The paper, published in Nature Communications on March 2, describes the production of a common designer polysaccharide, chondroitin sulfate.Read More
DNA Script to contribute to DARPA's mobile vaccine manufacturing platform DNA Script has been selected by GE Research to join a collaboration to develop a rapid response, mobile medical manufacturing platform to enable on-demand production of nucleic acid-based vaccines and therapies. The project is part of a Defense Advanced Research Projects Agency (DARPA) program.Read More
Mesoblast gets $110M in financing from investor group Mesoblast has entered into a subscription agreement to form a limited partnership with SurgCenter Development, a U.S.-based investor group, for a total of $110 million via the issue of 60 million shares.Read More
WuXi AppTec acquires Oxgene, adding to its CGT capabilities WuXi AppTec has completed the acquisition of Oxgene, a U.K.-based contract research and development organization that designs and develops scalable gene therapy technologies. The acquisition will allow WuXi to provide its customers with end-to-end support in the creation and development of cell and gene therapies (CGT), according to the company.Read More